Home  |  Contact

Cellosaurus PC346Enza (CVCL_RA54)

[Text version]
Cell line name PC346Enza
Accession CVCL_RA54
Resource Identification Initiative To cite this cell line use: PC346Enza (RRID:CVCL_RA54)
Comments Selected for resistance to: ChEBI; CHEBI:68534; Enzalutamide (Xtandi; MDV-3100).
Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
Disease Prostate carcinoma (NCIt: C4863)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_4883 (PC-346C)
Sex of cell Male
Age at sampling Age unspecified
Category Cancer cell line
Publications

PubMed=24200698; DOI=10.1016/j.ejca.2013.09.026
van Soest R.J., van Royen M.E., de Morree E.S., Moll J.M., Teubel W., Wiemer E.A.C., Mathijssen R.H.J., de Wit R., van Weerden W.M.
Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer.
Eur. J. Cancer 49:3821-3830(2013)

Cross-references
Encyclopedic resources Wikidata; Q54938577
Entry history
Entry creation05-Mar-2018
Last entry update29-Jun-2023
Version number6